Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Butler, R.
Right arrow Articles by Gallo, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butler, R.
Right arrow Articles by Gallo, J. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 7, 121-127, Copyright © 1998 by Oxford University Press

ARTICLES

Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy

R Butler, PN Leigh, MJ McPhaul and JM Gallo
Department of Clinical Neurosciences, Institute of Psychiatry and King's College School of Medicine and Dentistry, De Crespigny Park, London SE5 8AF, UK.

X-linked spinal and bulbar muscular atrophy (SBMA) is a rare form of motor neuron degeneration linked to a CAG repeat expansion in the first exon of the androgen receptor gene coding for a polyglutamine tract. In order to investigate the properties of the SBMA androgen receptor in neuronal cells, cDNAs coding for a wild-type (19 CAG repeats) and a SBMA mutant androgen receptor (52 CAG repeats) were transfected into mouse neuroblastoma NB2a/d1 cells. The full length androgen receptor proteins, of 110-112 kDa and 114-116 kDa for the wild-type and mutant protein, respectively, were detected by Western blotting in transfected cells. In addition, the presence of an expanded polyglutamine tract in the SBMA androgen receptor appears to enhance the production of C- terminally truncated fragments of the protein. A 74 kDa fragment was particularly prominent in cells expressing the SBMA androgen receptor. From its size, it can be deduced that the 74 kDa fragment lacks the hormone binding domain but retains the DNA binding domain. The 74 kDa fragment may therefore be toxic to motor neurons by initiating the transcription of specific genes in the absence of hormonal control. Immunofluorescence microscopy on transfected NB2a/d1 cells showed that, after hormone activation, the wild-type androgen receptor translocated to the nucleus whereas the SBMA androgen receptor was mainly localized in the cytoplasm in the form of dense aggregates with very little androgen receptor protein in the nucleus. This could explain the reduction in transcriptional activity of the SBMA mutant as compared with wild-type androgen receptor.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
J. P. Chapple, K. Anthony, T. R. Martin, A. Dev, T. A. Cooper, and J.-M. Gallo
Expression, localization and tau exon 10 splicing activity of the brain RNA-binding protein TNRC4
Hum. Mol. Genet., November 15, 2007; 16(22): 2760 - 2769.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. P. Pelley, K. Chinnakannu, S. Murthy, F. M. Strickland, M. Menon, Q. P. Dou, E. R. Barrack, and G. P.-V. Reddy
Calmodulin-Androgen Receptor (AR) Interaction: Calcium-Dependent, Calpain-Mediated Breakdown of AR in LNCaP Prostate Cancer Cells
Cancer Res., December 15, 2006; 66(24): 11754 - 11762.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. Goti, S. M. Katzen, J. Mez, N. Kurtis, J. Kiluk, L. Ben-Haiem, N. A. Jenkins, N. G. Copeland, A. Kakizuka, A. H. Sharp, et al.
A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration
J. Neurosci., November 10, 2004; 24(45): 10266 - 10279.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
C. M. Everett and N. W. Wood
Trinucleotide repeats and neurodegenerative disease
Brain, November 1, 2004; 127(11): 2385 - 2405.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. K. Lee and C. Chang
Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4043 - 4054.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
D.M. Avila, D.R. Allman, J.-M. Gallo, and M.J. McPhaul
Androgen Receptors Containing Expanded Polyglutamine Tracts Exhibit Progressive Toxicity when Stably Expressed in the Neuroblastoma Cell Line, SH-SY 5Y
Experimental Biology and Medicine, September 1, 2003; 228(8): 982 - 990.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
V. Gorbunova, A. Seluanov, V. Dion, Z. Sandor, J. L. Meservy, and J. H. Wilson
Selectable System for Monitoring the Instability of CTG/CAG Triplet Repeats in Mammalian Cells
Mol. Cell. Biol., July 1, 2003; 23(13): 4485 - 4493.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
T. Okuda, H. Hattori, S. Takeuchi, J. Shimizu, H. Ueda, J. J. Palvimo, I. Kanazawa, H. Kawano, M. Nakagawa, and H. Okazawa
PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype
Hum. Mol. Genet., April 1, 2003; 12(7): 711 - 725.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. L. Walcott and D. E. Merry
Ligand Promotes Intranuclear Inclusions in a Novel Cell Model of Spinal and Bulbar Muscular Atrophy
J. Biol. Chem., December 20, 2002; 277(52): 50855 - 50859.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H.Y. E. Chan, J. M. Warrick, I. Andriola, D. Merry, and N. M. Bonini
Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila
Hum. Mol. Genet., November 1, 2002; 11(23): 2895 - 2904.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Dejager, H. Bry-Gauillard, E. Bruckert, B. Eymard, F. Salachas, E. LeGuern, S. Tardieu, R. Chadarevian, P. Giral, and G. Turpin
A Comprehensive Endocrine Description of Kennedy's Disease Revealing Androgen Insensitivity Linked to CAG Repeat Length
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3893 - 3901.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
N. J. Caplen, J. P. Taylor, V. S. Statham, F. Tanaka, A. Fire, and R. A. Morgan
Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference
Hum. Mol. Genet., January 1, 2002; 11(2): 175 - 184.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
M. Becker, E. Martin, J. Schneikert, H. F. Krug, and A. C.B. Cato
Cytoplasmic Localization and the Choice of Ligand Determine Aggregate Formation by Androgen Receptor with Amplified Polyglutamine Stretch
J. Cell Biol., April 17, 2000; 149(2): 255 - 262.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. A. Irvine, H. Ma, M. C. Yu, R. K. Ross, M. R. Stallcup, and G. A. Coetzee
Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
Hum. Mol. Genet., January 22, 2000; 9(2): 267 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Simeoni, M. A. Mancini, D. L. Stenoien, M. Marcelli, N. L. Weigel, M. Zanisi, L. Martini, and A. Poletti
Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract
Hum. Mol. Genet., January 1, 2000; 9(1): 133 - 144.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. D. Kaytor and S. T. Warren
Aberrant Protein Deposition and Neurological Disease
J. Biol. Chem., December 31, 1999; 274(53): 37507 - 37510.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.